Disagree
Home Pharmacom Labs Pharmacom Labs
LETROS 2.5
LETROS 2.5 - Pharmacom Labs

LETROS 2.5 - Pharmacom Labs

Brand:
Category:
Substance:
Dosage:
2.5 mg/tab
Package:
100 tablets
Price:
$38.00 - $114.00
See options
Product Overview

Sold under the brand name Femara, Letrozole approved by the  Food and Drug Administration in 1997. It is a 3rd GEN aromatase-inhibitor. Its primarily used to lower estrogen in postmenopausal women with breast cancer. Beyond its medical use, it is employed by bodybuilders to control estrogen lvl during steroid cycles and prevent side effects like gynecomastia.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about LETROS 2.5 by Pharmacom Labs, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Does Letrozole cause bone loss?
Yes it can decrease bone mineral density increasing the risk of osteoporosis.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Is Letrozole hepatotoxic?
No significant liver toxicity has been noted, but prolonged use may have other health implications​.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

How exactly does Letrozole compare to other aromatase inhibitors?
Letrozole is more potent than first-generation inhibitors like Teslac and Cytadren.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.